A study of 52,236 patients with cancer found that episodes of unintended weight loss affected 46.63% of patients and were tied to shorter overall survival.
|Articles|June 16, 2012
- Summer 2012
- Volume 11
- Issue 2
CT Challenge Survivorship Summit
Author(s)Jon Garinn
Advertisement
The CT Challenge Survivorship Summit will bring together leaders in the field of survivorship to discuss trends and issues survivors face.
Scheduled for Nov. 13 in New Haven, Conn., the event will feature presentations by psychologists Karen Syrjala, PhD, and Mitch Golant, PhD; gynecologic oncologist Elena Ratner, MD; genetic counselor Ellen Matloff; researcher Melinda Irwin, PhD; and oncologist Kenneth Miller, MD. For details, visit
Articles in this issue
over 14 years ago
Tips on Finding Insurance Coverage for Cancer Rehabilitationover 14 years ago
Two Congressional Bills on Colorectal Cancer Introducedover 14 years ago
Recognizing Actinic Keratosisover 14 years ago
Leukemia Survival Rates Greatly Improved, Study Saysover 14 years ago
Q&A: Counterfeit Chemotherapy Drugs Cause Concernover 14 years ago
EPA Plans to Cut Radon Program, Despite Continued Cancer Riskover 14 years ago
Better, Stronger, Happierover 14 years ago
Questions to Ask About a Clinical Trialover 14 years ago
Expressing One’s Thoughtsover 14 years ago
Myths About the Dying ProcessAdvertisement
Related to this article
Diagnosed with leukemia at 8 years old, Harper feared that losing her hair would change who she was. She reflects on body image, confidence and finding a sense of herself during cancer treatment.
A psycho-oncologist answers 5 common questions about cancer-related anxiety, depression, fear of recurrence and emotional well-being.
U.S. counties where more residents had medical debt in collections had higher rates of late-stage lung, head and neck, colorectal and several other cancers, according to a study of 2,958 counties published in October 2026 in JAMA Network Open.
Diagnosed with stage 4 breast cancer weeks after giving birth, Eileen Carter explains why getting a second opinion changed the course of her care.
Libtayo survival data, a rare positive osteosarcoma trial and new ADCs for breast, lung and stomach cancers are among ESMO 2026 abstracts to watch.
Diagnosed with bone cancer at 14, college setter Gabby Orlet shares how volleyball, honesty and her family carried her through years of treatment.
In the phase 3 RT CHARM trial, published Oct. 12, 2026, in the Journal of Clinical Oncology, a three-week course of radiation after mastectomy caused about the same rate of reconstruction complications as the standard five-week course in women with breast cancer.
Advertisement
Advertisement
Trending on CURE
1
Diagnosed With Stage 4 Breast Cancer Weeks After Giving Birth
2
Libtayo, Osteosarcoma and More: 5 Other ESMO 2026 Abstracts to Watch
3
Stage 4 Breast Cancer: How a Second Opinion Saved Her Life
4
What Is a Personalized Cancer Vaccine? What Patients Should Know
5